What is hydroxyzine (Atarax) used for? Anxiety and sleep explained

What is hydroxyzine used for?

Hydroxyzine is a sedating antihistamine. Some products are authorised for anxiety or itching; feeling sleepy after a dose is not the same as having a medicine approved for insomnia. For example, the UK tablet product cited below lists adult anxiety and certain itching conditions, not insomnia. Check the exact product and country before assuming the same indication applies.

If hydroxyzine is being considered for sleep, ask the prescriber what is causing the sleep problem, whether the use is outside the local licence, and when treatment will be reviewed. This guide does not recommend it as a routine sleep aid.

How it works and what to expect

Hydroxyzine blocks histamine activity and can cause sedation. Drowsiness may affect alertness and driving. Dry mouth, dizziness and blurred vision can also occur. Alcohol and other sedating medicines can increase impairment: tell the prescriber about sleeping tablets, opioids, antihistamines and other medicines.

It is not a benzodiazepine, but that distinction does not justify a promise of no dependence, withdrawal or problems when stopping. Ask for an individual review and stopping plan rather than extending a prescription because it feels helpful.

Dose limits are safety limits, not sleep instructions

The EMA's heart-rhythm risk measures call for the lowest effective dose for the shortest duration. They limit adults to 100 mg per day; use in older adults is not recommended, and the maximum is 50 mg per day if use is unavoidable. These are ceilings, not suggested doses for insomnia. Kidney or liver impairment and other medicines can require additional restrictions.

Do not choose a bedtime dose from a general guide or add an extra dose after a poor night. Follow the prescription and local leaflet.

The QT-prolongation warning

Hydroxyzine can prolong the heart's electrical recovery interval, called QT, and cause dangerous rhythm disturbances. EMA restrictions exclude people with known QT prolongation or relevant risks, including cardiovascular disease, significant slow heart rate, low potassium or magnesium, a family history of sudden cardiac death, or medicines that prolong QT.

A clinician or pharmacist should check the full medicine list before treatment. Pregnancy, breastfeeding and other conditions also need assessment under the particular product information.

If heart palpitations, fainting or breathing difficulty develop, stop taking hydroxyzine and seek immediate medical attention. Severe symptoms need emergency care.

When sleep problems need a different approach

Persistent insomnia warrants assessment of sleep habits, anxiety, medicines and possible sleep disorders. NHS guidance describes cognitive behavioural therapy as one option for ongoing insomnia. A sedating effect alone does not resolve the underlying cause.

Information and clinical decisions

This guide provides general information, not a diagnosis or personal treatment plan. Any clinical assessment and prescribing decision rests with an independent clinician. Prescrivia is a technology intermediary, not a medical provider or pharmacy; it does not prescribe, sell or dispense medicines. Assessment does not guarantee a prescription, medicine availability or a health outcome.

Further reading: treatment information.

Read about online consultations and their limits. Service information must not delay urgent local care.

Sources

1. UK hydroxyzine 25 mg product information — Product-specific anxiety and itching indications, sedation, interactions and special-population cautions.
2. EMA hydroxyzine safety restrictions — Dose ceilings, older-adult restrictions, QT contraindications and action for heart-rhythm symptoms.
3. NHS: insomnia — Assessment of persistent sleep problems and the role of cognitive behavioural therapy.

See the current clinical, legal and language review statuses for this edition. Source checks are editorial work, not approval.